Many unbalanced translocations show duplication of a translocation participant. Clinical and cytogenetic implications in myeloid hematologic malignancies

American Journal of Hematology

Volumn 64, Issue 3, 2000, Pages 161-169

  Pedersen, Bent ^a,e   Nørgaard, Jan M ^b   Pedersen, Bjarne Bach ^c   Clausen, Niels ^b   Rasmussen, Inge Helleberg ^d   Thorling, Karen ^b  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c VIBORG HOSPITAL   (Denmark)

^d HOLSTEBRO HOSPITAL   (Denmark)

^e NONE   (Denmark)

Author keywords

Duplication; Leukemia; Myelodysplasia; Survival; Trisomy; Unbalanced translocation

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD DISEASE; CHILD; CHROMOSOME LOSS; CYTOGENETICS; DISOMY; FEMALE; GENE TRANSLOCATION; GENOME; HUMAN; INFANT; KARYOTYPE; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MONOSOMY; MYELODYSPLASIA; PRIORITY JOURNAL; SURVIVAL TIME; TRISOMY;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 7; FEMALE; HUMANS; KARYOTYPING; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; TRANSLOCATION, GENETIC; TRISOMY;

EID: 0034131188     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200007)64:3<161::AID-AJH4>3.0.CO;2-Q     Document Type: Article

References (22)

1. Pedersen-Bjergaard J, Rowley JD. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood 1994;83:2780-2786.
2. Pedersen B. Survival of patients with t(1;7)(p11;p11). Report of two cases and review of the literature. Cancer Genet Cytogenet 1992;60: 53-59.
3. nd edition. New York: Alan R. Liss Inc.; 1995.
4. ISCN. Guidelines for Cancer Cytogenetics, Supplement to An International System for Human Cytogenetic Nomenclature. 1991.
5. Yunis JJ. New chromosome techniques in the study of human neoplasia. Hum Pathol 1981;12:540-549.
6. Pedersen B, Kerndrup G. Specific minor chromosome deletions consistently occurring in myelodysplastic syndromes. Cancer Genet Cytogenet 1986;23:61-75.
7. Sachs L. Applied statistics: a handbook of techniques. New York: Springer-Verlag; 1978.
8. Parmar MKB, Machin D. Survival analysis: a practical approach. Chichester: John Wiley and Sons; 1995.
9. Horiike S, Taniwaki M, Misawa S, Abe T. Chromosome abnormalities and karyotypic evolution in 83 patients with myelodysplastic syndrome and predictive value for prognosis. Cancer 1988;62:1129-1138.
10. Le Beau MM, Albain KS, Larson RA, Vardiman JW, Davis EM, Blough RR, Golomb HM, Rowley JD. Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7. J Clin Oncol 1986;4:325-345.
11. Larson RA, Wernli M, Le Beau MM, Daly KM, Pape LH, Rowley JD, Vardiman JW. Short remission durations in therapy-related leukemia despite cytogenetic complete responses to high-dose cytarabine. Blood 1988;72:1333-1339.
12. Pedersen-Bjergaard J, Philip P. Cytogenetic characteristics of therapy-related acute nonlymphocytic leukemia, preleukemia and acute myeloproliferative syndrome: correlation with clinical data for 61 consecutive cases. Br J Haematol 1987;66:199-207.
13. Pedersen-Bjergaard J, Philip P, Olesen Larsen S, Jensen G, Byrsting K. Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemia. Blood 1990;76: 1083-1091.
14. Ohyashiki K, Sasao I, Ohyashiki JH, Murakami T, Iwabuchi A, Tauchi T, Saito M, Nakazawa S, Serizawa H, Ebihara Y, Toyama K. Clinical and cytogenetic characteristics of myelodysplastic syndromes developing myelofibrosis. Cancer 1991;68:178-183.
15. Sole F, Prieto F, Badia L, Woessner S, Florensa L, Caballin MR, Coll MD, Besses C, Sans Sabrafen J. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes. Cancer Genet Cytogenet 1992; 64:12-20.
16. Kobayashi H, Maseki N, Homma C, Sakurai M, Kaneko Y. Clinical significance of chromosome abnormalities in childhood acute lymphoblastic leukemia in Japan. Leukemia 1994;8:1944-1950.
17. Perot C, Akker Jv, Laporte JP, Douay L, Lopez M, Stachowiak J, Isnard F, Taillemite JL, Najman A, Gorin NC. Multiple chromosome abnormalities in patients with acute leukemia after autologous bone marrow transplantation using total body irradiation and marrow purged with Mafosfamide. Leukemia 1993;7:509-515.
18. Parlier V, Vanmelle G, Beris P, Schmidt P, Tobler A, Haller E, Bellomo MJ. Hematologic, clinical, and cytogenetic analysis in 109 patients with primary myelodysplastic syndrome - prognostic significance of morphology and chromosome findings. Cancer Genet Cytogenet 1994;78:219-231.
19. Alitalo T, Willard HF, Chapelle A. Determination of the breakpoints of 1;7 translocations in myelodysplastic syndrome by in situ hybridization using chromosome-specific α satellite DNA from human chromosomes 1 and 7. Cytogenet Cell Genet 1989;50:49-53.
20. Hasle H, Clausen N, Pedersen B, Bendix-Hansen K. Myelodysplastic syndrome in a child with constitutional trisomy 8 mosaicism and normal phenotype. Cancer Genet Cytogenet 1995;79:79-81.
21. Hindkjaer J, Hammoudah SAFM, Bendix-Hansen K, Jensen PD, Koch J, Pedersen B. Translocation (1;16) identified by chromosome painting and Primed In Situ-Labeling (PRINS). Report of two cases and review of the literature. Cancer Genet Cytogenet 1995;79:15-20.
22. th edition. New York: Wiley-Liss Inc.; 1994.